Skip to Main Content

Paper Details

Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatment.
Blood Rev
13
2014
Author NameAffiliation
Denis-Claude RoyHopital Maisonneuve-Rosemont Research Center, Universite de Montreal
  • 1 - 1

Datasets

Release 1.2